Andrea Shergalis

Andrea Shergalis

AbbVie Inc - Chicago / United States
Others
AD Scientific Index ID: 4403630
-
person_outline Andrea Shergalis's MOST POPULAR ARTICLES
1-) Current challenges and opportunities in treating glioblastomaA Shergalis, A Bankhead, U Luesakul, N Muangsin, N NeamatiPharmacological reviews 70 (3), 412-445, 20184552018
2-) Role of the ERO1-PDI interaction in oxidative protein folding and diseaseAG Shergalis, S Hu, A Bankhead III, N NeamatiPharmacology & Therapeutics, 107525, 2020502020
3-) Discovery and mechanistic elucidation of a class of protein disulfide isomerase inhibitors for the treatment of glioblastomaA Kyani, S Tamura, S Yang, A Shergalis, S Samanta, Y Kuang, ...ChemMedChem 13 (2), 164-177, 2018392018
4-) Activation of the unfolded protein response via inhibition of protein disulfide isomerase decreases the capacity for DNA repair to sensitize glioblastoma to radiotherapyY Liu, W Ji, A Shergalis, J Xu, AM Delaney, A Calcaterra, A Pal, ...Cancer research 79 (11), 2923-2932, 2019522019
5-) Inhibition of protein disulfide isomerase in glioblastoma causes marked downregulation of DNA repair and DNA damage response genesS Xu, Y Liu, K Yang, H Wang, A Shergalis, A Kyani, A Bankhead III, ...Theranostics 9 (8), 2282, 2019442019